Manufacturing Whitepaper: CDMOs at a Crossroads BioSpaceIn this whitepaper, BioSpace reviews the major trends impacting the CDMO sector and the evolving relationship between sponsors and providers.ManufacturingRead full story pharminent April 15, 2026 BioSpace In this whitepaper, BioSpace reviews the major trends impacting the CDMO sector and the evolving relationship between sponsors and providers. ManufacturingRead full story Post navigation Previous: Scientists issue call to arms over antifungal resistanceNext: BMS makes a Beeline, bringing 5 assets to biotech’s $300M precision immunology debut Related Stories Manufacturing Samsung Biologics inks $262M manufacturing deal with European pharma company pharminent September 11, 2026 Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision pharminent September 9, 2026 Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026